Th17-inducing dendritic cell vaccines stimulate effective CD4 T cell-dependent antitumor immunity in ovarian cancer that overcomes resistance to immune checkpoint blockade

Th17-inducing dendritic cell vaccines stimulate effective CD4 T cell-dependent antitumor immunity in ovarian cancer that overcomes resistance to immune checkpoint blockade

Background Ovarian cancer (OC), a highly lethal cancer in women, has a 48% 5-year overall survival rate. Prior studies link the presence of IL-17 and Th17 T cells in the tumor microenvironment to improved survival in OC patients. To determine if Th17-inducing vaccines are therapeutically effective i...

Full description

Bibliographic Details
Main Authors:	Yan Luo, Matthew S Block, Barath Shreeder, James W Jenkins, Huashan Shi, Purushottam Lamichhane, Kexun Zhou, Deborah A Bahr, Sophia Kurian, Katherine A Jones, Joshua I Daum, Navnita Dutta, Brian M Necela, Martin J Cannon, Keith L Knutson
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-11-01
Series:	Journal for ImmunoTherapy of Cancer
Online Access:	https://jitc.bmj.com/content/11/11/e007661.full

Similar Items

Blockades of effector T cell senescence and exhaustion synergistically enhance antitumor immunity and immunotherapy
by: Xia Liu, et al.
Published: (2022-10-01)

Blockade of novel immune checkpoints and new therapeutic combinations to boost antitumor immunity
by: Adrià Archilla-Ortega, et al.
Published: (2022-02-01)

TNFR2 blockade of regulatory T cells unleashes an antitumor immune response after hematopoietic stem-cell transplantation
by: Moatti, A, et al.
Published: (2022)

TNFR2 blockade of regulatory T cells unleashes an antitumor immune response after hematopoietic stem-cell transplantation
by: Frédéric Charlotte, et al.
Published: (2022-04-01)

MCL1 inhibition targets Myeloid Derived Suppressors Cells, promotes antitumor immunity and enhances the efficacy of immune checkpoint blockade
by: Nabanita Mukherjee, et al.
Published: (2024-03-01)

SIRPα blockade improves the antitumor immunity of radiotherapy in colorectal cancer
by: Kai Ji, et al.
Published: (2023-06-01)

Photothermally sensitive gold nanocage augments the antitumor efficiency of immune checkpoint blockade in immune “cold” tumors
by: Guixiu Xiao, et al.
Published: (2023-10-01)

In situ vaccination with cowpea mosaic virus elicits systemic antitumor immunity and potentiates immune checkpoint blockade
by: Veronique Beiss, et al.
Published: (2022-12-01)

B7-H5 blockade enhances CD8+ T-cell-mediated antitumor immunity in colorectal cancer
by: Jiayu Wang, et al.
Published: (2021-09-01)

Dendritic cell therapy augments antitumor immunity triggered by CDK4/6 inhibition and immune checkpoint blockade by unleashing systemic CD4 T-cell responses
by: Roman Uzhachenko, et al.
Published: (2023-05-01)

Durable antitumor responses to CD47 blockade require adaptive immune stimulation
by: Sockolosky, Jonathan T., et al.
Published: (2016)

Correction: Dendritic cell therapy augments antitumor immunity triggered by CDK4/6 inhibition and immune checkpoint blockade by unleashing systemic CD4 T-cell responses
Published: (2023-06-01)

Motility Dynamics of T Cells in Tumor-Draining Lymph Nodes: A Rational Indicator of Antitumor Response and Immune Checkpoint Blockade
by: Yasuhiro Kanda, et al.
Published: (2021-09-01)

Rethinking immune checkpoint blockade: ‘Beyond the T cell’
by: Xiuting Liu, et al.
Published: (2021-01-01)

Combination of immune checkpoint blockade and targeted gene regulation of angiogenesis for facilitating antitumor immunotherapy
by: Jing Zhan, et al.
Published: (2023-03-01)

Adaptive antitumor immune response stimulated by bio-nanoparticle based vaccine and checkpoint blockade
by: Xuewei Bai, et al.
Published: (2022-04-01)

TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBM
by: Alice L. Hung, et al.
Published: (2018-08-01)

Factors Determining Long-Term Antitumor Responses to Immune Checkpoint Blockade Therapy in Melanoma
by: Kimberly Loo, et al.
Published: (2022-01-01)

Antigen presenting cells in cancer immunity and mediation of immune checkpoint blockade
by: Wang, Cassia, et al.
Published: (2024)

Antitumor effects of TIM‐1 blockade in B cells
by: Wenwen Liu, et al.
Published: (2024-03-01)

Creatine in T Cell Antitumor Immunity and Cancer Immunotherapy
by: Bo Li, et al.
Published: (2021-05-01)

γδT cells: alternative treasure in antitumor immunity
by: Xiangjin Zhang, et al.
Published: (2022-02-01)

Combination of immune checkpoint blockade with DNA cancer vaccine induces potent antitumor immunity against P815 mastocytoma
by: Lopes, A, et al.
Published: (2018)

Systemic inflammation shapes clinical outcomes in response to immune checkpoint blockade treatment: moving toward optimizing antitumor immunity
by: Ming Zheng
Published: (2023-03-01)

Combination of immune checkpoint blockade with DNA cancer vaccine induces potent antitumor immunity against P815 mastocytoma
by: Alessandra Lopes, et al.
Published: (2018-10-01)

Blockade of the immunosuppressive KIR2DL5/PVR pathway elicits potent human NK cell–mediated antitumor immunity
by: Xiaoxin Ren, et al.
Published: (2022-11-01)

3,3′-Diindolylmethane improves antitumor immune responses of PD-1 blockade via inhibiting myeloid-derived suppressor cells
by: Qi Sun, et al.
Published: (2022-06-01)

Combining an adenovirus encoding human endostatin and PD‐1 blockade enhanced antitumor immune activity
by: Yaomei Tian, et al.
Published: (2023-03-01)

Pirfenidone facilitates immune infiltration and enhances the antitumor efficacy of PD-L1 blockade in mice
by: Wan Qin, et al.
Published: (2020-01-01)

The Emerging Role of NK Cells in Immune Checkpoint Blockade
by: Alejandra Martinez-Perez, et al.
Published: (2022-12-01)

Myeloid Cells as Clinical Biomarkers for Immune Checkpoint Blockade
by: Elisa Peranzoni, et al.
Published: (2020-07-01)

Combination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunity
by: Xiao Yang, et al.
Published: (2022-01-01)

Regulation of Antitumor Immune Responses by Exosomes Derived from Tumor and Immune Cells
by: Andrés Rincón-Riveros, et al.
Published: (2021-02-01)

Cancer Cell Membrane Camouflaged Mesoporous Silica Nanoparticles Combined with Immune Checkpoint Blockade for Regulating Tumor Microenvironment and Enhancing Antitumor Therapy
by: Zhao P, et al.
Published: (2021-03-01)

Editorial: Progress of programmed cell death in antitumor immunity
by: Fangfang Yan, et al.
Published: (2023-06-01)

Roles of CD4+ T cells as mediators of antitumor immunity
by: Dmitriy S. Kravtsov, et al.
Published: (2022-09-01)

Epigenetic Regulation of NK Cell-Mediated Antitumor Immunity
by: Miaoran Xia, et al.
Published: (2021-05-01)

Combined mitoxantrone and anti-TGFβ treatment with PD-1 blockade enhances antitumor immunity by remodelling the tumor immune landscape in neuroblastoma
by: Valeria Lucarini, et al.
Published: (2022-11-01)

Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer
by: Guru Sonpavde, et al.
Published: (2021-11-01)

Ibrutinib Inhibits BTK Signaling in Tumor-Infiltrated B Cells and Amplifies Antitumor Immunity by PD-1 Checkpoint Blockade for Metastatic Prostate Cancer
by: Gengguo Deng, et al.
Published: (2023-04-01)